FDA Restricts J&J's COVID-19 Vaccine Due To Blood Clot Risk

FDA Restricts J&J's COVID-19 Vaccine Due To Blood Clot Risk

Newsy

Published

Watch VideoU.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.

The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J's vaccine. U.S....

Full Article